Published in DICP on September 01, 1989
Botulinum toxin versus pneumatic dilatation in the treatment of achalasia: a randomised trial. Gut (1999) 2.44
Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia. Neurology (1998) 2.30
Chronic nausea in advanced cancer patients: a retrospective assessment of a metoclopramide-based antiemetic regimen. J Pain Symptom Manage (1996) 2.09
Is there a chiropractic science? J Manipulative Physiol Ther (1990) 1.94
Randomized, double-blind, cross-over trial comparing safety and efficacy of oral controlled-release oxycodone with controlled-release morphine in patients with cancer pain. J Clin Oncol (1998) 1.88
Treatment of achalasia: the best of both worlds. Am J Gastroenterol (1994) 1.82
Sulfasalazine toxic reactions. Hepatitis, fever, and skin rash with hypocomplementemia and immune complexes. JAMA (1978) 1.49
Diabetes and related metabolic risk factors among Arab Americans. Ann Pharmacother (1995) 1.36
Pharmacokinetics and pharmacodynamic modeling of direct suppression effects of methylprednisolone on serum cortisol and blood histamine in human subjects. Clin Pharmacol Ther (1989) 1.32
Efficacy of controlled-release codeine in chronic non-malignant pain: a randomized, placebo-controlled clinical trial. Pain (1995) 1.29
Vancomycin pharmacokinetics in a patient population: effect of age, gender, and body weight. Ther Drug Monit (1994) 1.24
Alpha1-acid glycoprotein concentration and protein binding in trauma. Clin Pharmacol Ther (1982) 1.23
Double blind randomized placebo control trial of controlled release codeine in the treatment of osteoarthritis of the hip or knee. J Rheumatol (2000) 1.22
Proximal gastric vagotomy: effects of two operative techniques on clinical and gastric secretory results. Ann Surg (1976) 1.20
Circulating concentrations of di(2-ethylhexyl) phthalate and its de-esterified phthalic acid products following plasticizer exposure in patients receiving hemodialysis. Toxicol Appl Pharmacol (1985) 1.13
The effect of renal failure on hepatic drug clearance. DICP (1991) 1.06
Parotid gland swelling developing during peroral endoscopy. Gastrointest Endosc (1975) 1.00
Factors influencing serum protein binding of lidocaine in humans. Anesth Analg (1981) 0.99
Relationship of serum antibiotic concentrations to nephrotoxicity in cancer patients receiving concurrent aminoglycoside and vancomycin therapy. Am J Med (1987) 0.98
Effects of ketoconazole on methylprednisolone pharmacokinetics and cortisol secretion. Clin Pharmacol Ther (1986) 0.96
Chloramphenicol sodium succinate kinetics in critically ill patients. Clin Pharmacol Ther (1980) 0.96
Pharmacokinetics and pharmacodynamics of methylprednisolone in obesity. Clin Pharmacol Ther (1991) 0.95
Submaxillary salivary gland swelling developing during peroral endoscopy. Gastroenterology (1969) 0.94
Seizures associated with high cerebrospinal fluid concentrations of cefazolin. Am J Hosp Pharm (1980) 0.91
Itraconazole and hydroxyitraconazole serum concentrations are reduced more than tenfold by phenytoin. Clin Pharmacol Ther (1995) 0.90
Randomised trial of oral morphine for painful episodes of sickle-cell disease in children. Lancet (1997) 0.89
Factors affecting quinidine protein binding in humans. J Pharm Sci (1984) 0.89
Endoscopic diagnosis of sliding-type diaphragmatic hiatal hernias. Am J Dig Dis (1968) 0.89
Appropriateness of the use of serum digoxin and digitoxin assays. Am J Hosp Pharm (1978) 0.89
Chloramphenicol pharmacokinetics in hospitalized patients. Antimicrob Agents Chemother (1979) 0.88
Evaluation of dextrose 50 % as a medium for injection-assisted polypectomy. Endoscopy (2006) 0.88
Pharmacokinetics of ketoconazole administered intravenously to dogs and orally as tablet and solution to humans and dogs. J Pharm Sci (1986) 0.88
Comparison of pharmacokinetics and pharmacodynamics of short- and long-term glyburide therapy in NIDDM. Diabetes Care (1994) 0.87
Comparative clinical efficacy and safety of a novel controlled-release oxycodone formulation and controlled-release hydromorphone in the treatment of cancer pain. Cancer (1997) 0.86
Comparative clinical efficacy and safety of immediate release and controlled release hydromorphone for chronic severe cancer pain. Cancer (1994) 0.85
Displacement of lidocaine from serum alpha 1-acid glycoprotein binding sites by basic drugs. Eur J Clin Pharmacol (1983) 0.84
The effects of a beta-2 selective adrenergic agonist and a beta-nonselective antagonist on theophylline clearance. J Clin Pharmacol (1987) 0.84
Steady-state pharmacokinetic evaluation of a novel, controlled-release morphine suppository and subcutaneous morphine in cancer pain. J Clin Pharmacol (1995) 0.83
The effect of stress on glycemic control in patients with type II diabetes during glyburide and glipizide therapy. J Clin Pharmacol (1993) 0.83
The pharmacokinetics of meperidine in acute trauma patients. J Trauma (1986) 0.83
Portal vein thrombosis resulting in portal hypertension in adults. Am J Gastroenterol (1976) 0.83
Effect of smoking on binding of lidocaine to human serum proteins. J Pharm Sci (1980) 0.82
Lack of effect of smoking on the metabolism and pharmacokinetics of quinidine in patients. Br J Clin Pharmacol (1987) 0.81
Steroid dose sparing: pharmacodynamic responses to single versus divided doses of methylprednisolone in man. J Allergy Clin Immunol (1990) 0.81
Hydromorphone metabolite accumulation in renal failure. J Pain Symptom Manage (1995) 0.80
A double-blind, crossover study of controlled-release metoclopramide and placebo for the chronic nausea and dyspepsia of advanced cancer. J Pain Symptom Manage (2000) 0.80
Use of concurrent monitoring and a preprinted note to modify prescribing of i.v. cimetidine and ranitidine in a teaching hospital. Am J Hosp Pharm (1989) 0.79
Total and unbound concentrations of quinidine and 3-hydroxyquinidine at steady state. Am Heart J (1987) 0.79
Randomized evaluation of controlled-release codeine and placebo in chronic cancer pain. J Pain Symptom Manage (1995) 0.79
Lack of effect of atenolol on the pharmacokinetics of theophylline. Br J Clin Pharmacol (1988) 0.79
Simultaneous analysis of methylprednisolone hemisuccinate, cortisol and methylprednisolone by normal-phase high-performance liquid chromatography in human plasma. J Chromatogr (1988) 0.79
Multiple bolus technique for lidocaine administration in acute ischemic heart disease. II. Treatment of refractory ventricular arrhythmias and the pharmacokinetic significance of severe left ventricular failure. J Am Coll Cardiol (1983) 0.78
Ketoconazole effects on methylprednisolone disposition and their joint suppression of endogenous cortisol. Clin Pharmacol Ther (1987) 0.78
High-performance liquid chromatographic procedure for the determination of di-(2-ethylhexyl)phthalate in human blood specimens. Problems of variable-extraction yield and the use of standard addition for calibration. J Chromatogr (1984) 0.78
The influence of multiple dosing and age on the pharmacokinetics and pharmacodynamics of glipizide in patients with type II diabetes mellitus. Pharmacotherapy (1997) 0.77
Correlation of lower esophageal sphincter pressure and serum gastrin level in man. Am J Dig Dis (1975) 0.77
The pharmacokinetics and pharmacodynamics of 12 weeks of glyburide therapy in obese diabetics. Eur J Clin Pharmacol (1993) 0.77
Steady-state pharmacokinetics of hydromorphone and hydromorphone-3-glucuronide in cancer patients after immediate and controlled-release hydromorphone. J Clin Pharmacol (1995) 0.76
Re: Use of rectal medications in palliative care. J Pain Symptom Manage (1997) 0.75
The pharmacokinetics and pharmacodynamics of quinidine and 3-hydroxyquinidine. Br J Clin Pharmacol (1988) 0.75
Reliability and accuracy of memory for acute pain. Pain (1994) 0.75
Putative role of hydromorphone metabolites in myoclonus. Pain (1992) 0.75
Relationship between serum and saliva chloramphenicol concentrations. Antimicrob Agents Chemother (1979) 0.75
Effects of cimetidine and ranitidine on the pharmacokinetics of a chronotherapeutically formulated once-daily theophylline preparation (Uniphyl). Clin Ther (1993) 0.75
Differential effect of pentobarbital and chloralose in anesthetic doses on the serum protein binding of lidocaine in the dog. J Pharm Sci (1988) 0.75
Lidocaine clinical pharmacokinetics. Drug Intell Clin Pharm (1982) 0.75
Lack of effect of intravenous erythromycin lactobionate on theophylline clearance. J Allergy Clin Immunol (1980) 0.75
Blood sampling errors: a problem and challenge for therapeutic drug monitoring services. Drug Intell Clin Pharm (1985) 0.75
Effects of hemodialysis on the pharmacokinetics of amoxicillin/clavulanic acid combination. Ther Drug Monit (1984) 0.75
Serum theophylline profile with once-daily theophylline (Uniphyl) following conversion from intravenous theophylline in adult asthmatic patients. Clin Ther (1994) 0.75
Effect of hemodialysis on total body clearance of chloramphenicol. Am J Hosp Pharm (1980) 0.75
Exchange transfusion in the treatment of patients with acute hepatitis in coma. Am J Dig Dis (1970) 0.75
Endoscopic removal of an intragastric segment of retained nasogastric tube. Gastrointest Endosc (1973) 0.75
Steroid-specific effects of ketoconazole on corticosteroid disposition: unaltered prednisolone elimination. DICP (1989) 0.75
Hepatic drug clearance following traumatic injury. Drug Intell Clin Pharm (1985) 0.75
Viral infections of the liver. Ala J Med Sci (1985) 0.75
Pharmacokinetics of two novel rectal controlled-release morphine formulations. J Pain Symptom Manage (1992) 0.75
Severe theophylline toxicity. Am J Med (1985) 0.75
Double lumen esophagus due to reflux esophagitis with fibrous septom formation. Gastroenterology (1976) 0.75
Evaluation and use of opioid analgesics in pediatric cancer pain. J Palliat Care (1993) 0.75
Minimally invasive palliative tumor therapy guided by imaging techniques: the UCLA experience. J Clin Laser Med Surg (1994) 0.75
Letter: Laubry-Soulle syndrome. JAMA (1975) 0.75
Intraindividual variability in theophylline pharmacokinetics in subjects with mild/moderate asthma. J Allergy Clin Immunol (1987) 0.75
Hydromorphone and metabolite pharmacokinetics in children. J Pain Symptom Manage (1995) 0.75
Hemodialysis clearance of theophylline. Ther Drug Monit (1982) 0.75
Intrasubject variability of theophylline clearance in a morbidly obese patient. Drug Intell Clin Pharm (1986) 0.75
Comparison of assay procedures used to measure total and unbound concentrations of quinidine. DICP (1989) 0.75
Localized saccular dilatation of the esophagus: an unusual cause of dysphagia. Gastrointest Radiol (1981) 0.75
Clinical efficacy and safety of a novel controlled-release morphine suppository and subcutaneous morphine in cancer pain: a randomized evaluation. J Clin Oncol (1995) 0.75
Establishing a pharmacy-based therapeutic drug monitoring service. Drug Intell Clin Pharm (1985) 0.75
Theophylline clearance in obese patients in relation to smoking and congestive heart failure. Drug Intell Clin Pharm (1983) 0.75
The toxicity of tricyclic antidepressants. JAMA (1987) 0.75
Sliding type esophageal hiatal hernia. Med Times (1968) 0.75